January 2023

Arowana Named the Best Impact Investor in the 2023 Real Leaders Top Impact Awards

arowana real leaders impact awards 2023

We are humbled to announce that Arowana has once again made it to the prestigious list. This year, we ranked as the 35th-best purpose-driven business globally and the best in #ImpactInvesting for 2023.

For Arowana, this is the 4th straight year we have been honoured to be part of the Impact Awards. We debuted on the list in 2020, and since then, we have consistently ranked in the top 50 global companies despite the growing list of entries every year.

Founded in 2010, Real Leaders is a membership community for impact leaders powered by a global media platform. Its mission is to unite farsighted leaders to transform our short-sighted world.

Now in its 5th year, the Real Leaders Impact Awards honour companies that are driving positive impact while achieving impressive business growth. Driven by a proprietary ‘Force for Good’ score, the Impact Awards takes into account the 5-year sales growth, revenue, and B Impact Assessment (or default score) while ranking the companies.

This latest recognition shows Arowana's dedication to creating a meaningful impact in the community through our business. Our primary purpose continues to be to deliver the #BCorp triple bottom line of People, Planet, and Profit, and we are proud to have been recognised again by Real Leaders for our commitment to this purpose.

Visit the Real Leaders website to view the full list of 2023 Impact Awards winners.

Stay tuned to Arowana for more News & Insights.

Read More

November 2024

Investing in People: Advancing Gender Equality at Work through Diversity, Equity, and Inclusion

November 2024

Investing in People: How to Drive Innovation and Growth through Workplace Diversity

September 2024

Announcement on Intueri Class Action Lawsuit

September 2024

VivoPower announces strategic merger heads of agreement with FAST at a pro-forma combined equity value of US$1.13bn

September 2024

VivoPower secures Mpox diagnostic tests distribution heads of agreement for Singapore, Hong Kong and Australia with Sansure Biotech

August 2024

Tembo E-LV Executes a Definitive Business Combination Agreement with CCTS for a Combined Enterprise Value of US$904 Million

1 2 3 26
crossmenu